What is Vor Biopharma's AOCI?

Vor Biopharma (VOR) reported AOCI of -$706K in Q1 2026.

How has Vor Biopharma's AOCI changed year-over-year?

Vor Biopharma's AOCI decreased by 3169.6% year-over-year, from $23K to -$706K.

What is the long-term trend for Vor Biopharma's AOCI?

Over 3 years (2022 to 2025), Vor Biopharma's AOCI has grown at a -62.4% compound annual growth rate (CAGR), from -$770K to $41K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Vor Biopharma VOR AOCI

AOCI at other companies

Johnson & JohnsonJNJ

-$14.83B-26.3%

AmgenAMGN

-$190M+17.7%

Vertex PharmaceuticalsVRTX

$24.8M-63.6%

Dianthus TherapeuticsDNTH

-$575K-313%

Design Therapeutics, Inc.DSGN

-$268K-160%

Cullinan Therapeutics, Inc.CGEM

$127K-74.9%

Other financials

Income statement

See full

Operating income-$35.2M-5.6%

Net income-$219.6M-576%

EPS (diluted)-$5.11+1.9%

Balance sheet

See full

Cash & equivalents$169.9M+239%

Total debt$2.9M-90.5%

Total equity-$150.4M-328%

Total assets$506.7M+364%

Cash flow

See full

Operating cash flow-$38.2M-23.1%

CapEx$48.0K-79.2%

Free cash flow-$38.3M-22.4%

Valuation

See full

Market cap$784.61M+2,594%

Enterprise value$617.68M+5,866%

Returns & leverage

See full

Return on equity-125.4%+671pp

Debt / equity0.5×+0.2×

Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vor Biopharma's AOCI?: Vor Biopharma (VOR) reported AOCI of -$706K in Q1 2026.
How has Vor Biopharma's AOCI changed year-over-year?: Vor Biopharma's AOCI decreased by 3169.6% year-over-year, from $23K to -$706K.
What is the long-term trend for Vor Biopharma's AOCI?: Over 3 years (2022 to 2025), Vor Biopharma's AOCI has grown at a -62.4% compound annual growth rate (CAGR), from -$770K to $41K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.